BANB — BACHEM HOLDING AG Share Price
Last trade - 00:00- CH₣3.68bn
- CH₣3.58bn
- CH₣605.26m
- 79
- 16
- 19
- 27
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 25.38 | ||
| PEG Ratio (f) | 1.7 | ||
| EPS Growth (f) | 17.58% | ||
| Dividend Yield (f) | 1.94% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.64 | ||
| Price to Tang. Book | 2.69 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.08 | ||
| EV to EBITDA | 20.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.1% | ||
| Return on Equity | 8.87% | ||
| Operating Margin | 21.97% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CH₣m | 402 | 503.23 | 531.74 | 577.32 | 605.26 | 705.27 | 954.51 | 14.05% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +42.54 | +45.05 | -15.64 | +10.12 | +6.69 | +7.83 | +36.99 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Directors
- Kuno Sommer NEC (64)
- Thomas Meier CEO (52)
- Nicole Hotzer NVC (47)
- Stephan Schindler CFO (57)
- Roland Schuermann COO (56)
- Gunther Loidl CTO (50)
- Anne-Kathrin Stoller CMO (46)
- Jurgen Brokatzky-Geiger NED (68)
- Thomas Fruh NED (62)
- Steffen Lang NED (54)
- Helma Wennemers NED (51)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 16th, 1971
- Public Since
- June 29th, 2001
- No. of Shareholders
- 9,811
- No. of Employees
- 2,207
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- SIX Swiss Exchange
- Shares in Issue
- 74,971,893
- Address
- Hauptstrasse 144, BUBENDORF, 4416
- Web
- https://www.bachem.com/
- Phone
- +41 619352333
- Contact
- Daniel Grotzky
- Auditors
- Forvis Mazars
Latest News for BANB
Upcoming Events for BANB
Bachem Holding AG Annual Shareholders Meeting
Dividend For BANB.S - 0.4300 CHF
Dividend For BANB.S - 0.4200 CHF
Dividend For BCHMY.PK - 0.0490 USD
Half Year 2025 Bachem Holding AG Earnings Release
Similar to BANB
Addex Therapeutics
SIX Swiss Exchange
Basilea Pharmaceutica AG Allschwil
SIX Swiss Exchange
BB Biotech AG
SIX Swiss Exchange
BioVersys AG
SIX Swiss Exchange
Evolva Holding
SIX Swiss Exchange
FAQ
As of Today at 19:28 UTC, shares in BACHEM HOLDING AG are trading at CH₣49.06. This share price information is delayed by 15 minutes.
Shares in BACHEM HOLDING AG last closed at CH₣49.06 and the price had moved by -38.02% over the past 365 days. In terms of relative price strength the BACHEM HOLDING AG share price has underperformed the FTSE Global All Cap Index by -39.57% over the past year.
The overall consensus recommendation for BACHEM HOLDING AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe BACHEM HOLDING AG dividend yield is 1.73% based on the trailing twelve month period.
Last year, BACHEM HOLDING AG paid a total dividend of CH₣0.85, and it currently has a trailing dividend yield of 1.73%.Looking ahead, shares in BACHEM HOLDING AG are due to go ex-dividend on 2025-05-05 and the next dividend pay date is 2025-05-07.
BACHEM HOLDING AG are due to go ex-dividend on 2025-05-05 and the next dividend pay date is 2025-05-07. The historic dividend yield on BACHEM HOLDING AG shares is currently 1.73%.
To buy shares in BACHEM HOLDING AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CH₣49.06, shares in BACHEM HOLDING AG had a market capitalisation of CH₣3.68bn.
Here are the trading details for BACHEM HOLDING AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: BANB
Based on an overall assessment of its quality, value and momentum BACHEM HOLDING AG is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in BACHEM HOLDING AG is CH₣70.17. That is 43.03% above the last closing price of CH₣49.06.
Analysts covering BACHEM HOLDING AG currently have a consensus Earnings Per Share (EPS) forecast of CH₣1.73 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BACHEM HOLDING AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -29.05%.
As of the last closing price of CH₣49.06, shares in BACHEM HOLDING AG were trading -25.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BACHEM HOLDING AG PE ratio based on its reported earnings over the past 12 months is 25.38. The shares last closed at CH₣49.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BACHEM HOLDING AG's management team is headed by:
- Kuno Sommer - NEC
- Thomas Meier - CEO
- Nicole Hotzer - NVC
- Stephan Schindler - CFO
- Roland Schuermann - COO
- Gunther Loidl - CTO
- Anne-Kathrin Stoller - CMO
- Jurgen Brokatzky-Geiger - NED
- Thomas Fruh - NED
- Steffen Lang - NED
- Helma Wennemers - NED